Peter Hebert

Peter Hebert has an estimated net worth of $370 Million. This is based on reported shares across multiple companies, which include Science 37 Holdings, Inc., Lux Health Tech Acquisition Corp., RECURSION PHARMACEUTICALS, INC., Aeva Technologies, Inc., Latch, Inc., Matterport, Inc./DE, EVERSPIN TECHNOLOGIES INC, and Eikon Therapeutics, Inc..

2016 was Peter Hebert's most active year for acquiring shares with 5 total transactions. Peter Hebert's most active month to acquire stocks was the month of January. 2026 was Peter Hebert's most active year for disposing of shares, totalling 10 transactions. Peter Hebert's most active month to dispose stocks was the month of January. 2020 saw Peter Hebert paying a total of $8,899,999.50 for 5,953,464 shares, this is the most they've acquired in one year. In 2026 Peter Hebert cashed out on 42,472,241 shares for a total of $0.00, their largest year based on trade value.